Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2005
08/31/2005EP1567523A1 Indolyl derivatives
08/31/2005EP1567522A1 Pyrimidine compounds
08/31/2005EP1567520A2 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
08/31/2005EP1567515A2 Novel lapachone compounds and methods of use thereof
08/31/2005EP1567513A2 High enantiomeric purity dexanabinol for pharmaceutical copositions
08/31/2005EP1567509A2 Biphenyl compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
08/31/2005EP1567505A2 Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds
08/31/2005EP1567498A2 Mandelic acid derivatives
08/31/2005EP1567497A2 Pyridines for treating injured mammalian nerve tissue
08/31/2005EP1567493A1 Phenyl substituted piperidine compounds for use as ppar activators
08/31/2005EP1567492A2 N-arylsulfonyl-3-aminoalkoxyindoles
08/31/2005EP1567491A2 Compounds for inhibition of hiv infection by blocking hiv entry
08/31/2005EP1567490A2 Anti-sickling agents
08/31/2005EP1567487A2 Open chain prolyl urea-related modulators of androgen receptor function
08/31/2005EP1567477A1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
08/31/2005EP1567476A2 N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor
08/31/2005EP1567198A2 Materials and methods for treating ocular-related disorders
08/31/2005EP1567193A1 Colon cleansing compositions
08/31/2005EP1567183A2 Methods and compositions for treatment of otitis media
08/31/2005EP1567182A2 Preventing desensitization of receptors
08/31/2005EP1567181A2 Methods for treatment of helicobacter pylori-associated disorders
08/31/2005EP1567180A2 Methods of treating cognitive dysfunction by modulating brain energy metabolism
08/31/2005EP1567179A1 Irrigation solution and method for inhibition of tumor cell adhesion, pain and inflammation
08/31/2005EP1567174A2 Compositions for diabetes treatment and prophylaxis
08/31/2005EP1567173A2 A protectant for uv-induced skin damage
08/31/2005EP1567172A2 Formulations useful against hepatitis c virus infections
08/31/2005EP1567171A1 New use of dextran sulfate
08/31/2005EP1567170A2 Use of beta-glucans against biological warfare weapons and pathogens including anthrax
08/31/2005EP1567169A2 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
08/31/2005EP1567168A2 Method of treating sepsis-induced ards
08/31/2005EP1567167A2 Methods for treating gastroesophageal reflux disease
08/31/2005EP1567166A2 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
08/31/2005EP1567165A2 Water-soluble mesoporphyrin compounds and methods of preparation
08/31/2005EP1567164A1 Use of loxapine or amoxapine for the manufacture of a medicament for the treatment of pain
08/31/2005EP1567163A2 Method of treating nausea, vomiting, retching or any combination thereof
08/31/2005EP1567162A2 Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
08/31/2005EP1567161A2 Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof
08/31/2005EP1567160A2 Method of treatment of myocardial infarction
08/31/2005EP1567159A1 Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions
08/31/2005EP1567158A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
08/31/2005EP1567157A1 Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases
08/31/2005EP1567156A2 Hydroxypyridinones for the local treatment of skin microcirculatory disorders
08/31/2005EP1567155A2 Administration of dendritic cells partially matured in vitro for the treatment of tumors
08/31/2005EP1567154A2 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
08/31/2005EP1567153A2 Shivering supression during cooling to lower body temperature
08/31/2005EP1567152A2 Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
08/31/2005EP1567149A2 Pharmaceutical composition comprising beta-3-adrenoceptor agonists and antimuscarinic agents
08/31/2005EP1567148A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration
08/31/2005EP1567147A2 Water-soluble anionic bacteriochlorophyll derivatives and their uses
08/31/2005EP1567146A1 Iontophoretic delivery of rotigotine for the treatment of parkinson's disease
08/31/2005EP1567145A1 Analgesic uses of norketamine and ketamine/norketamine prodrugs
08/31/2005EP1567144A2 Method of making, and the use of cytotoxic agents containing elemental selenium
08/31/2005EP1567143A2 Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents
08/31/2005EP1567142A2 Treatment of lung cells with histone deacetylase inhibitors
08/31/2005EP1567141A1 Labeled macrophage scavenger receptor antagonists for imaging cardiovacular diseases
08/31/2005EP1567140A1 Synergistic combination comprising roflumilast and (r,r)-formoterol
08/31/2005EP1567139A1 New synergistic combination comprising roflumilast and formoterol
08/31/2005EP1567138A1 Use of diamide derivatives for inhibiting chronic tissue transplant rejection
08/31/2005EP1567137A1 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
08/31/2005EP1567136A1 Pde4 and pde3/4 inhibitors for use in the treatment of cachexia
08/31/2005EP1567135A2 Pulverulent formulation for inhalation containing tiotropium
08/31/2005EP1567134A2 Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
08/31/2005EP1567133A2 Pharmaceutical antiviral compositions
08/31/2005EP1567131A1 Bupropion hydrochloride solid dosage forms
08/31/2005EP1567130A2 Method of drug loading in liposomes by gradient
08/31/2005EP1567127A2 Method of modifying the release profile of sustained release compositions
08/31/2005EP1567126A2 Concentrated liquid valdecoxib composition
08/31/2005EP1567124A1 Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or bucally
08/31/2005EP1567117A1 Materials and methods for preventing and treating microbe-mediated epithelial disorders
08/31/2005EP1567113A2 Antifungal formulations
08/31/2005EP1567112A2 Novel chemical compounds
08/31/2005EP1567101A2 Prophylactic treatment methods
08/31/2005EP1567022A1 Sustained improver of muscular fatigue
08/31/2005EP1567008A2 Protection of stem cells from cytotoxic agents by modulation of beta-catenin signaling pathways
08/31/2005EP1567007A2 Compositions and methods for cancer diagnosis and therapy
08/31/2005EP1517914B1 9-alpha-substituted estratrienes as selectively active estrogen
08/31/2005EP1478437B1 Acc inhibitors
08/31/2005EP1461063A4 Treatment of glioblastoma with thymosin-alpha 1
08/31/2005EP1434570B1 Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline
08/31/2005EP1430057B1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives
08/31/2005EP1408929B1 Ophthalmic composition containing n-acetylcysteine for the treatment of dry-eye syndrom
08/31/2005EP1401405B1 Oral pharmaceutical compositions with improved bioavailability
08/31/2005EP1397359B1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
08/31/2005EP1395576B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
08/31/2005EP1392714B1 Steroids as agonists for fxr
08/31/2005EP1392288B1 Medicament containing an effector of the glutathione metabolism (ampbroxol) together with alpha-lipoic acid for treating diabetes mellitus
08/31/2005EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene
08/31/2005EP1382608B1 Sulfate of cephem compound
08/31/2005EP1370569B1 Process for preparing n6-substituted aminopurine ribofuranose nucleosides
08/31/2005EP1365764B1 Oral pharmaceutical composition of cefpodoxime proxetil
08/31/2005EP1363901A4 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles
08/31/2005EP1363516B1 An improved process for preparing simvastatin
08/31/2005EP1347978B1 Novel substituted imidazotriazinones as pde ii-inhibitors
08/31/2005EP1326598B1 Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
08/31/2005EP1294381B1 Neuroprotective 7-beta-hydroxysteroids
08/31/2005EP1289963B1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
08/31/2005EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines
08/31/2005EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
08/31/2005EP1259264A4 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
08/31/2005EP1244445B1 Use of azoles for preventing skin cancer due to radiation
1 ... 4560 4561 4562 4563 4564 4565 4566 4567 4568 4569 4570 4571 4572 4573 4574 4575 4576 4577 4578 4579 4580 ... 7860